We are committed to driving transformational healthcare for billions of people. Our work goes beyond the science taking place in our labs. We plan to disrupt how medicine is delivered to positively change the world.
We are focused on four priority and action areas when it comes to ESG with the goal to scale these efforts as the company grows.
Sustainability Through Four Priority Areas
Justice, Equity, Diversity, and Inclusion
Our mission is to be a leader in equitable access to medicines. Our employees are as diverse as the world around us, and our commitment is to ensure this type of representation in biotech.
Access to Quality Medicines
Our vision is to bring innovative medicines to billions of people around the world. We are pioneering a new way of offering access to critical potential therapies. In order to do so, quality must be built into all of our processes and procedures.
Safety of Clinical Trial Participants
We are committed to ensuring the safety of all patients enrolled in our clinical trials. Given the data seen to-date with our product candidates, it’s critical that we continue to create effective, safe, and well-tolerated medicines to ensure access for patients at all stages of disease.
Governing & Ethical Principles
Our executive team is deeply committed to implementing and supporting our ESG approach with Evelo’s Board of Directors providing oversight and valuable insight to the team. We strive to maintain a governance culture of inclusion, transparency, access, and accountability.